FLASCO is hosting a free educational program for patients and caregivers to learn and exchange information regarding a Nasopharyngeal Cancer (NPC) diagnosis. Our goal is to empower patients with the knowledge they need about treatment options, emerging therapies, symptom and side effect management, and resources available to navigate an NPC diagnosis. We aim to help…
Join for an exclusive event exploring the recent approval of ROMVIMZA™ (vimseltinib), a new treatment for adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will potentially cause worsening functional limitation or severe morbidity.
Join for an exclusive event exploring the recent approval of ROMVIMZA™ (vimseltinib), a new treatment for adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will potentially cause worsening functional limitation or severe morbidity.
© 2021 FLASCO | Premium Website Design by The HDG
